If the American people know anything, they understand homeland security.
The Chair thanks the gentlelady. That concludes the questions that we have here. We have follow-up questions. We will su...
In 2009, this committee passed the Biologics Price Competition and Innovation Act (BPCIA) by a vote of 47 to 11.
I am hoping that that can be moved to April 1st pursuant to the law.
I supported the creation of a pathway for biosimilars, and for empowering FDA with the authority and resources to ensure...
Biologics are used to treat a number of serious diseases and conditions and have improved the lives of millions of Ameri...
FDA approved the first biosimilar in March 2015 and is convening an advisory committee next week to consider a second ap...
Given the choice between paying higher prices and risking the lives of their patients, most hospitals choose to knuckle ...
I was concerned that CMS finalized its Part B payment policy for biosimilars last year combining all biosimilars into on...
And failure to do so would absolutely mislead about the nature of those risks.
If you have a loan that is made or guaranteed by the Federal Government through a vehicle like the Ex-Im Bank or more di...
We were failing in our statutory obligation and an obligation based on decency to do a budget.
I think CBO's hands are tied, is my understanding, into a methodology that does not sufficiently take into account the d...
So if you use that methodology for different borrowers, is it fair to say that that methodology fails to capture the dif...
what we see here is the responsible, the culpable party being caught red-handed
How crazy is that? How interested are we, really, in getting at the facts when they bring here witnesses who don't know ...
There is a systematic risk that we are underestimating the risks of the assets that we are claiming.
It is our job to counter the negative, the angry, and the wrongheadedness of some public officials who want to condemn t...
